Search Results - "Madon, E."

Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis by Vercelli, A, Mereuta, O.M, Garbossa, D, Muraca, G, Mareschi, K, Rustichelli, D, Ferrero, I, Mazzini, L, Madon, E, Fagioli, F

“…Abstract Amyotrophic lateral sclerosis (ALS) is a lethal disease affecting motoneurons. In familial ALS, patients bear mutations in the superoxide dismutase…”
Get full text

EP-1795: Evaluation of CBCT protocols in craniospinal RT for pediatric medulloblastoma: a preliminary study by Madon, E, Sardo, A, Sirgiovanni, S, Richetto, V, Mussano, A, Monetti, U, Urgesi, A

Get full text

Isolation of human mesenchymal stem cells : bone marrow versus umbilical cord blood by MARESCHI, Katia, BIASIN, Eleonora, PIACIBELLO, Wanda, AGLIETTA, Massimo, MADON, Enrico, FAGIOLI, Franca

Get full text

PV-0034: HDR BT alone in endometrial cancer: up-date of Piedmont experience in 18 years (71 patients) by Gribaudo, S, Monetti, U, Madon, E, Richetto, V, Tessa, M, Moretto, F, Ruggieri, A, Cosma, S, Danese, S, Urgesi, A

Get full text

Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality by Berger, M, Figari, O, Bruno, B, Raiola, A, Dominietto, A, Fiorone, M, Podesta, M, Tedone, E, Pozzi, S, Fagioli, F, Madon, E, Bacigalupo, A

“…To assess the kinetics of lymphocyte subset recovery, 758 allografted patients were monitored by surface markers (CD3, CD4, CD8, CD56), with a 5-year…”
Get full text

EP-1329: Vaginal and pelvic recurrences of endometrial carcinoma with BT HDR alone or in combination with EBRT by Gribaudo, S, Monetti, U, Mussano, A, La Sala, S, Madon, E, Richetto, V, Sardo, A, Rossi, A, Tessa, M, Moretto, F, Ruggieri, A, Delmastro, E, Cattari, G, Katsaros, Gabriele, P, Urgesi, A

Get full text

High-Dose Chemotherapy in the Treatment of Relapsed Osteosarcoma: An Italian Sarcoma Group Study by FAGIOLI, F, AGLIETTA, M, MADON, E, TIENGHI, A, FERRARI, S, BRACH DEL PREVER, A, VASSALLO, E, PALMERO, A, BIASIN, E, BACCI, G, PICCI, P

“…To study the feasibility and activity of two courses of high-dose chemotherapy (HDCT) in patients with osteosarcoma in metastatic relapse. Patients with…”
Get full text

Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells by Muraro, M., Mereuta, O.M., Carraro, F., Madon, E., Fagioli, F.

“…Bisphosphonates have a profound effect on bone resorption and are widely used in the treatment of osteoclast-mediated bone diseases. Zoledronic acid (ZA), a…”
Get full text

PO-1001: Ipsilateral Breast Tumour Recurrence (IBTR): Second conservative treatment with Interstitial HDR BRT by Gribaudo, S, De Sanctis, C, Durando, A, Katsaros, D, Porpiglia, M, Richetto, V, Madon, E, Monetti, U, Danese, S

Get full text

Poor prognosis osteosarcoma: new therapeutic approach by Fagioli, F, Biasin, E, Mereuta, O M, Muraro, M, Luksch, R, Ferrari, S, Aglietta, M, Madon, E

“…Over the past 30 years, a significant improvement in the prognosis of localized osteosarcoma of the extremities has been observed. Despite these results,…”
Get full text

PO-308 HDR BRT IN ENDOMETRIAL CANCER: EXPERIENCE OF TWO FRACTIONATION SCHEDULES AND RESULTS OF 14 YEARS WITH 57 PATIENTS by Gribaudo, S, Tessa, M, Madon, E, Richetto, V, Masenga, D, Monetti, U, Mussano, A, Urgesi, A, Nassisi, D, Cosma, S

Get full text

Dosimetric characterization of a large area pixel-segmented ionization chamber by Amerio, S., Boriano, A., Bourhaleb, F., Cirio, R., Donetti, M., Fidanzio, A., Garelli, E., Giordanengo, S., Madon, E., Marchetto, F., Nastasi, U., Peroni, C., Piermattei, A., Sanz Freire, C. J., Sardo, A., Trevisiol, E.

“…A pixel-segmented ionization chamber has been designed and built by Torino University and INFN. The detector features a 24×24  cm 2 active area divided in 1024…”
Get full text

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995 by CENTER, V, ARICO, M, RONDELLI, R, ZANESCO, L, MASERA, G, VALSECCHI, M. G, BASSO, G, BIONDI, A, MADON, E, MANDELLI, F, PAOLUCCI, G, PESSION, A, RIZZARI, C

“…The first multicentric approach to childhood acute lymphoblastic leukemia (ALL) treatment in Italy started in the early 1970s when the Associazione Italiana di…”
Get full text

Phase II trial of temozolomide in children with recurrent high-grade glioma by RUGGIERO, A, CEFALO, G, CALDARELLI, M, DI ROCCO, C, MADON, E, ABATE, M. E, CLERICO, A, SANDRI, A, RICCARDI, R, GARRD, M. L, MASSIMINO, M, COLOSIMO, C, ATTINA, G, LAZZARESCHI, I, MAURIZI, P, RIDOLA, V, MAZZARELLA, G

“…The objective of the study was to evaluate the efficacy and toxicity of Temozolomide (TMZ) administered for 5 consecutive days in three daily dosing in…”
Get full text

Diffuse and focal brain stem tumors in childhood: prognostic factors and surgical outcome. Experience in a single institution by Sandri, A, Sardi, N, Genitori, L, Giordano, F, Peretta, P, Basso, M E, Bertin, D, Mastrodicasa, L, Todisco, L, Mussa, F, Forni, M, Ricardi, U, Cordero di Montezemolo, L, Madon, E

“…Brainstem tumors (BSTs) are usually gliomas and are divided into diffuse BSTs (DBSTs) and focal BSTs (FBSTs). The aim of this study is to investigate the…”
Get full text

Two-dimensional and quasi-three-dimensional dosimetry of hadron and photon beams with the Magic Cube and the Pixel Ionization Chamber by Cirio, R, Garelli, E, Schulte, R, Amerio, S, Boriano, A, Bourhaleb, F, Coutrakon, G, Donetti, M, Giordanengo, S, Koss, P, Madon, E, Marchetto, F, Nastasi, U, Peroni, C, Santuari, D, Sardo, A, Scielzo, G, Stasi, M, Trevisiol, E

“…Two detectors for fast two-dimensional (2D) and quasi-three-dimensional (quasi-3D) verification of the dose delivered by radiotherapy beams have been developed…”
Get more information

Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing’s family tumours by Luksch, R, Grignani, G, Fagioli, F, del Prever, A. Brach, Podda, M, Aliberti, S, Casanova, M, Prete, A, Hanau, G, Tamburini, A, Allione, P, Tienghi, A, Ferrari, S, Collini, P, Marchianò, A, Gandola, L, Aglietta, M, Madon, E, Picci, P, Fossati-Bellani, F

“…Abstract The aim of the study was to determine the activity and toxicity of melphalan as a single agent given in up-front therapy for patients with…”
Get full text

SC28.03 QA DELIVERY PROTOCOL IN HIGH RESOLUTION PAEDIATRIC RT: A NOVEL MULTILEVEL APPROACH by Pipolo, C., Madon, E., Cornetto, A. Peruzzo, Sardo, A.

Get full text

Population-based survival after childhood lymphoblastic leukaemia in time periods corresponding to specific clinical trials from 1979 to 1998—a report from the Childhood Cancer Registry of Piedmont (Italy) by Pastore, G, Viscomi, S, Gerov, G.L, Terracini, B, Madon, E, Magnani, C

“…This study evaluated the outcome after childhood acute lymphoblastic leukaemia (ALL) in a population aged 0–14 years served by the Childhood Cancer Registry of…”
Get full text

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells by VALABREGA, G, FAGIOLI, F, CORSO, S, MADON, E, DEL PREVER, A. Brach, BIASIN, E, LINARI, A, AGLIETTA, M, GIORDANO, S

“…Osteosarcoma is the most common malignant bone neoplasia occurring in young patients in the first two decades of life, and represents 20% of all primitive…”
Get full text